Appropriateness of Antibiotics in China - 2nd Volume

Dear Colleagues,

From the ancient quinine to the newly synthesized oxazolidinones, antibiotics have drastically changed human civilization and modern medicine in just over 100 years. In medical institutions, antibiotics could be widely prescribed across all departments, patients, and treatment places. In the community pharmacy, antibiotics are one of the most commonly prescribed drugs. The appropriateness of antibiotics is a global issue and is mainly associated with factors, such as antibacterial resistance evaluation, the rational choice of drugs, the optimization of drug usage and dosage, and the management of drug adverse reaction and costs.

In China, antibiotic use has been strictly managed in hospitals, considering how widely it is used, the expenditure, and the serious consequences of antimicrobial abuse. Additionally, the bacterial resistance surveillance system is relatively well established in China, providing antibacterial resistance data for guidance on the appropriateness of antibiotics. Nevertheless, with the increasing complexity of clinical infection, the rational use of antibiotics in China still needs further research and improvement.

This Special Issue will focus on the appropriateness of antibiotics in China and invite scholars to report the latest research and review results. This Special Issue also seeks manuscript submissions that further improve our understanding and experience of rational antibiotic use in China.

After the successful first volume, we are delighted to launch a second volume, in which we hope to bring together the new advances in this exciting topic.

Prof. Dr. Siyan Zhan
Prof. Dr. Suodi Zhai
Dr. Pengxiang Zhou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.